Skip to main content

Interferon alfa-2a in the Treatment of Ocular Adamantiades-Behçet’s Disease

  • Chapter
Adamantiades-Behçet’s Disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Yazici, H., and Barnes, C.G., 1991, Practical treatment recommendations for pharmacotherapy of Behçet’s syndrome. Drugs 42: 796–804.

    CAS  PubMed  Google Scholar 

  2. Zouboulis, Ch.C., and Orfanos, C.E., 1998, Treatment of Adamantiades-Behçet disease with systemic interferon alfa. Arch. Dermatol. 134: 1010–1016.

    Article  CAS  PubMed  Google Scholar 

  3. Alpsoy, E., Durusoy, C., Yilmaz, E., et al., 2002, Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study. Arch. Dermatol. 138: 467–471.

    Article  CAS  PubMed  Google Scholar 

  4. Stuebiger, N., Koetter, I., Deuter, C., et al., 2001, M. Morbus Behçet: Uveitis-Therapie mit Interferon a2a — prospektive klinische (Pilot-)Studie an 33 Patienten. Klin. Monatsbl. Augenheilkd. 218:0768–773.

    Google Scholar 

  5. Wechsler, B., Bodaghi, B., Huong, D.L., et al., 2000, Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet’s disease. Ocul. Immunol. Inflamm. 8: 293–301.

    CAS  PubMed  Google Scholar 

  6. Krause, L., Adler, Y.D., Hoffmann, F., et al., 2000, Treatment of ocular Adamantiades-Behçet’s disease with interferon-alpha. Invest. Ophth. Vis. Sci. 41: 371.

    Google Scholar 

  7. Kötter, I., Eckstein, A.K., StÜbiger, N., et al., 1998, Treatment of ocular symptoms of Behçet’s disease with interferon-alpha-2a. Br. J. Ophthalmol. 82: 488–494.

    PubMed  Google Scholar 

  8. Ozdemir, O., Erkam, N., and Bakkaloglu, A., 1988, Results of pars plana vitrectomy in Behçet’s disease. Ann. Ophthalmol. 20: 35, 38.

    CAS  PubMed  Google Scholar 

  9. Ozerturk, Y., Bardak, Y., and Durmus, M., 2001, Vitreoretinal surgery in Behçet’s disease with severe ocular complications. Acta Ophthalmol. Scand. 79: 192–196.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Krause, L., Turnbull, J.R., Torun, N., Pleyer, U., Zouboulis, C.C., Foerster, M.H. (2004). Interferon alfa-2a in the Treatment of Ocular Adamantiades-Behçet’s Disease. In: Zouboulis, C.C. (eds) Adamantiades-Behçet’s Disease. Advances in Experimental Medicine and Biology, vol 528. Springer, Boston, MA. https://doi.org/10.1007/0-306-48382-3_103

Download citation

  • DOI: https://doi.org/10.1007/0-306-48382-3_103

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-47757-7

  • Online ISBN: 978-0-306-48382-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics